Compare ADMA Biologics Inc (ADMA) vs Jabil Inc (JBL) Price & Performance

ADMA Biologics IncTrade

Jabil IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Jabil Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Jabil Inc trades at $362.37 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 16.8× ADMA Biologics Inc's market cap, and Jabil Inc pays a 0.09% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

	ADMA	JBL
Market Cap	$2.22B	$37.37B
Sector	Health	Technology
52-Week High	$20.38	$385.50
52-Week Low	$7.60	$192.49
Enterprise Value	$2.29B	$39.90B
Dividend Yield	—	0.09%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ADMA

View details →

JBL

UBS upgrades Jabil, citing AI, healthcare, and automation growth with a $430 price target.Proactive Investors · 20 hours agoBullish Jabil expands into full data center services, targeting $40B revenue and $13.6B AI revenue by 2026.Seeking Alpha · 1 day agoBullish View details →

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

About Jabil Inc

Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.